No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
RXRX240816P8000
- 0.65
- +0.29+80.56%
15min DelayClose Jul 24 15:59 ET
0.65High0.53Low
0.60Open0.36Pre Close34 Volume526 Open Interest8.00Strike Price1.98KTurnover67.96%IV5.89%PremiumAug 16, 2024Expiry Date0.19Intrinsic Value100Multiplier23DDays to Expiry0.46Extrinsic Value100Contract SizeAmericanOptions Type-0.5155Delta0.2999Gamma12.50Leverage Ratio-0.0110Theta-0.0026Rho-6.44Eff Leverage0.0078Vega
Intraday
- 5D
- Daily
News
Trending Industry Today: Nano X Imaging Leads Gains In NVIDIA Holdings Stocks
Trending Industry Today: SoundHound AI Leads Losses In NVIDIA Holdings Stocks
Trending Industry Today: Arm Holdings Leads Losses In NVIDIA Holdings Stocks
Trending Industry Today: SoundHound AI Leads Losses Pre-Market In NVIDIA Holdings Stocks
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings
Is Recursion Pharmaceuticals Stock a Buy?
Comments
$Recursion Pharmaceuticals(RXRX.US$ trying to fill that gap when they announced that filthy stock sale to raise funds
$Schrodinger(SDGR.US$ i have been saying this for days and weeks now but if you're looking for a time to buy small caps now is the time it's still not too late these small caps have massive price gaps they need to fill they'll be forming giant cup and handles and many of them have been bottoming for the longest time while the mag7 were carrying the whole SPY & QQQ
they just needed a catalyst from rate cuts and this expectation is enough to tr...
they just needed a catalyst from rate cuts and this expectation is enough to tr...
7
Last week, Nvidia $NVIDIA(NVDA.US$ briefly eclipsed Microsoft $Microsoft(MSFT.US$ as the world’s most valuable company. The AI chip maker is now worth $3.3 trillion… or roughly the combined value of every residential property in the state of Florida. Shares trade for 50 times forward earnings.
That caused expected hand-wringing on Wall Street.
“We’re not necessarily at peak bubble levels,” said Jonathan Stubbs of Berenberg, a wealth management fi...
That caused expected hand-wringing on Wall Street.
“We’re not necessarily at peak bubble levels,” said Jonathan Stubbs of Berenberg, a wealth management fi...
34
2
$Recursion Pharmaceuticals(RXRX.US$
prospectus of secondary offering resolves two key areas in 4-6 quarters with funds coveing potentially dozensof clinical trials as well as acquisitions.
In May, Recursion also stated that they have future partnerships as well as current partners whose trials include non-dilutive funding as these clical trials progress.
Increased my stake by 15%![]()
prospectus of secondary offering resolves two key areas in 4-6 quarters with funds coveing potentially dozensof clinical trials as well as acquisitions.
In May, Recursion also stated that they have future partnerships as well as current partners whose trials include non-dilutive funding as these clical trials progress.
Increased my stake by 15%
7
Read more